Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence Update for Tezepelumab to Treat Severe Uncontrolled Asthma, Corticosteroid-dependent Asthma, Chronic Rhinosinusitis With Nasal Polyposis, and Chronic Obstructive Pulmonary Disease. 2nd Barcelona Respiratory Network report.

Open respiratory archives·2026
Same author

Development of an artificial intelligence prediction model for moderate-to-severe COPD exacerbations using continuous multiple unobtrusive sensors: protocol of a multicentre prospective observational study.

BMJ open respiratory research·2026
Same author

Bronchial and Systemic Relationships of <i>Haemophilus</i> in Chronic Obstructive Pulmonary Disease.

International journal of molecular sciences·2026
Same author

Sex-Specific Plasma Metabolomic Signatures in COPD Reveal Creatine, Purine/Urate, and Bile-Acid Axes.

Metabolites·2026
Same author

Assessing Physician Agreement in Biologic Therapy Initiation and Selection in Patients with Severe Asthma.

Open respiratory archives·2026
Same author

Expert Opinion and Evidence-Based Review on Maintenance Therapy Step-Down in Patients With Severe Asthma Controlled With Biologics.

Open respiratory archives·2026

Related Experiment Video

Updated: Jun 16, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

[Skeletal muscle dysfunction in COPD].

Joaquim Gea1, Juana Martínez-Llorens, Pilar Ausín

  • 1Servicio de Neumología, Hospital del Mar-IMIM, Departamento de Ciencias Experimentales y de Salud, Universidad Pompeu Fabra, CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Barcelona, España. jgea@imim.es

Archivos De Bronconeumologia
|February 2, 2010
PubMed
Summary

Muscle dysfunction in chronic obstructive pulmonary disease (COPD) varies by muscle group. Respiratory muscles adapt, while limb muscles decline, necessitating tailored therapies for COPD patients.

More Related Videos

Myo-mechanical Analysis of Isolated Skeletal Muscle
08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 22, 2011

Related Experiment Videos

Last Updated: Jun 16, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Myo-mechanical Analysis of Isolated Skeletal Muscle
08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 22, 2011

Area of Science:

  • Pulmonary Medicine
  • Muscle Physiology
  • Disease Pathogenesis

Context:

  • Chronic obstructive pulmonary disease (COPD) significantly impacts skeletal muscle function.
  • Muscle dysfunction in COPD is heterogeneous, affecting both respiratory and limb muscles.
  • Understanding these differences is crucial for managing COPD symptoms and prognosis.

Purpose:

  • To differentiate the causes and characteristics of muscle dysfunction in respiratory versus limb muscles in COPD patients.
  • To explore the distinct pathophysiological mechanisms contributing to muscle impairment in different muscle groups.
  • To inform the development of targeted therapeutic strategies for COPD-related muscle dysfunction.

Summary:

  • Respiratory muscles in COPD patients exhibit overactivity and unfavorable geometry, yet show adaptive phenotypes.
  • Limb muscles in COPD patients display involutive changes and relative inactivity, contributing to overall dysfunction.
  • Systemic factors like inflammation, nutritional deficits, hypoxia, and comorbidities exacerbate muscle impairment across all groups.

Impact:

  • Highlights the need for distinct therapeutic approaches, such as nutritional support, exercise, or rest, tailored to specific muscle groups.
  • Improves understanding of COPD pathophysiology, potentially leading to better patient outcomes and quality of life.
  • Provides a basis for future research into novel interventions targeting muscle-specific pathways in COPD.